Bristol-Myers Squibb (BMY) Reports Q4 Adj-EPS of 47c, Misses by 1c; Guides FY11 Below the Street

January 27, 2011 7:32 AM EST Send to a Friend
Get Alerts BMY Hot Sheet
Trade BMY Now!
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.47, $0.01 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.04 billion.

Sees FY11 adj-EPS of $2.10-$2.20, vs. cons. $2.25.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance, Hot Earnings, Hot List

Add Your Comment